Theranica’s Nerivio, a prescription wearable device used to mitigate migraines, went from being a reactive approach of treating symptoms to a proactive tool for helping prevent them. Earlier this year and just a few months after submitting a new 510(k) to expand indications for the technology, the FDA cleared the device for people who experience migraines with or without aura and who are at least 12 years old. Theranica is eyeing expansion beyond the U.S. and has partnered with Dr. Reddy’s in India and is working to Bring the device to China and Japan.